Article Text
Abstract
Neuropsychological testing is a key diagnostic tool for assessing people with dementia and mild cognitive impairment, but can also help in other neurological conditions such as Parkinson’s disease, stroke, multiple sclerosis, traumatic brain injury and epilepsy. While cognitive screening tests offer gross information, detailed neuropsychological evaluation can provide data on different cognitive domains (visuospatial function, memory, attention, executive function, language and praxis) as well as neuropsychiatric and behavioural features. We should regard neuropsychological testing as an extension of the neurological examination applied to higher order cortical function, since each cognitive domain has an anatomical substrate. Ideally, neurologists should discuss the indications and results of neuropsychological assessment with a clinical neuropsychologist. This paper summarises the rationale, indications, main features, most common tests and pitfalls in neuropsychological evaluation.
- dementia
- cognitive neuropsychology
- alzheimer-s disease
- neuropsychology
- cognition
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study
- Neuropsychological characteristics of mild cognitive impairment subgroups
- Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia
- ‘Under pressure’: is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?
- Single photon emission computed tomography perfusion differences in mild cognitive impairment
- Evidence for cortical dysfunction in clinically non-demented patients with Parkinson’s disease: a proton MR spectroscopy study
- Remote versus face-to-face neuropsychological testing for dementia research: a comparative study in people with Alzheimer’s disease, frontotemporal dementia and healthy older individuals
- Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration
- Cognitive functioning after subthalamic nucleotomy for refractory Parkinson's disease
- Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease